Trupanion (NASDAQ:TRUP)‘s stock had its “buy” rating reaffirmed by equities researchers at Northland Securities in a research note issued to investors on Thursday. They presently have a $38.00 target price on the financial services provider’s stock. Northland Securities’ price target would indicate a potential upside of 20.87% from the stock’s previous close.
Several other research firms have also recently weighed in on TRUP. BidaskClub raised Trupanion from a “hold” rating to a “buy” rating in a research report on Monday, December 18th. Zacks Investment Research raised Trupanion from a “hold” rating to a “buy” rating and set a $37.00 price objective on the stock in a research report on Wednesday, November 8th. CL King assumed coverage on Trupanion in a research report on Tuesday, November 21st. They issued a “neutral” rating on the stock. Finally, Canaccord Genuity reissued a “buy” rating and issued a $35.00 price objective (up previously from $29.00) on shares of Trupanion in a research report on Tuesday, October 31st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $31.33.
Trupanion (NASDAQ:TRUP) traded down $0.61 during mid-day trading on Thursday, reaching $31.44. The company’s stock had a trading volume of 280,126 shares, compared to its average volume of 252,587. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.87 and a current ratio of 1.87. Trupanion has a twelve month low of $13.88 and a twelve month high of $36.88. The stock has a market capitalization of $979.16, a PE ratio of -349.33 and a beta of 0.34.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Nine Ten Capital Management LLC lifted its position in shares of Trupanion by 3.4% during the 3rd quarter. Nine Ten Capital Management LLC now owns 1,374,967 shares of the financial services provider’s stock valued at $36,313,000 after buying an additional 45,100 shares during the last quarter. Baillie Gifford & Co. lifted its position in shares of Trupanion by 2.4% during the 3rd quarter. Baillie Gifford & Co. now owns 1,005,983 shares of the financial services provider’s stock valued at $26,568,000 after buying an additional 23,610 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Trupanion by 16.6% during the 2nd quarter. Vanguard Group Inc. now owns 758,594 shares of the financial services provider’s stock valued at $16,977,000 after buying an additional 108,135 shares during the last quarter. State Street Corp lifted its position in shares of Trupanion by 54.4% during the 2nd quarter. State Street Corp now owns 346,367 shares of the financial services provider’s stock valued at $7,752,000 after buying an additional 121,990 shares during the last quarter. Finally, Jupiter Asset Management Ltd. raised its stake in shares of Trupanion by 3.0% during the 3rd quarter. Jupiter Asset Management Ltd. now owns 311,671 shares of the financial services provider’s stock valued at $8,231,000 after purchasing an additional 9,171 shares during the period. 63.76% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Trupanion (TRUP) Receives “Buy” Rating from Northland Securities” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/02/08/trupanion-trup-receives-buy-rating-from-northland-securities.html.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.